Novartis announces the company’s fourth quarter and 2022 full year financial results.
Novartis in Society Integrated Report 2022
The Novartis in Society Integrated Report covers our business, strategy and performance. It highlights progress against our ESG targets and describes how we create value for diverse stakeholders. View the interactive report.
Annual Report 2022
This report, filed with the SIX Swiss Exchange in Switzerland, provides a comprehensive overview of Novartis, including our company structure, corporate governance and compensation practices. It also contains our operating and financial results, accompanied by audited annual financial statements.
In our work to reimagine medicine, we made a real and measurable difference last year in the lives of patients all around the world.— Vas Narasimhan (@VasNarasimhan) February 1, 2023
I share some highlights and what 2022 meant for @novartis in the video below. https://t.co/rCuqTlc2m5 pic.twitter.com/sggDz7TTxq
Benefiting from our continued focus on innovation, Novartis has one of the industry’s most competitive pipelines.
Executive Committee of Novartis (ECN) biographies
Under the leadership of Vasant Narasimhan, the Executive Committee of Novartis (ECN) is responsible for overseeing the business operations of Group companies.